Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,887 | -29,539 | -21,201 | -11,614 | -5,168 |
| Depreciation Amortization | 13 | 36 | 26 | 18 | 1 |
| Other Working Capital | -110 | 1,163 | 2,550 | 812 | -821 |
| Other Operating Activity | 1,197 | 821 | 372 | 128 | 32 |
| Operating Cash Flow | $-8,787 | $-27,519 | $-18,253 | $-10,656 | $-5,956 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -74 | -50 | -7 | N/A |
| Investing Cash Flow | $-19 | $-74 | $-50 | $-7 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,990 | N/A | N/A | N/A | N/A |
| Debt Repayment | -4,770 | N/A | N/A | 0 | N/A |
| Common Stock Issued | 63 | 93,402 | 51 | 8 | N/A |
| Other Financing Activity | 0 | 87,633 | 86,702 | 43,548 | 43,655 |
| Financing Cash Flow | $283 | $181,035 | $86,753 | $43,556 | $43,655 |
| Beginning Cash Position | 157,366 | 3,924 | 3,924 | 3,924 | 3,924 |
| End Cash Position | 148,843 | 157,366 | 72,374 | 36,817 | 41,623 |
| Net Cash Flow | $-8,523 | $153,442 | $68,450 | $32,893 | $37,699 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,787 | -27,519 | -18,253 | -10,656 | -5,956 |
| Capital Expenditure | -19 | -74 | -50 | -7 | N/A |
| Free Cash Flow | -8,806 | -27,593 | -18,303 | -10,663 | -5,956 |